
Prolog Ventures
Description
Prolog Ventures is a venture capital firm based in St. Louis, United States, dedicated to investing in companies that promote healthy lives in a healthy world. Established in 2000, the firm has built a robust portfolio focused on the natural products, health and wellness, food, and sustainability sectors. Their investment philosophy centers on supporting innovative businesses that address critical consumer needs and contribute positively to environmental and personal well-being.
The firm typically targets early-stage companies, ranging from Seed to Series A rounds, where they can provide not just capital but also strategic guidance and operational support. Prolog Ventures seeks out companies with strong management teams, disruptive technologies or business models, and significant market potential within their niche. Their long-standing presence in the venture ecosystem, having been founded over two decades ago, speaks to their deep experience and commitment to their specialized investment areas.
Prolog Ventures manages over $100 million in capital, which they deploy to foster growth in their portfolio companies. They have made over 40 investments across various stages, demonstrating a consistent track record of identifying and backing promising ventures. The firm's hands-on approach involves working closely with founders to navigate challenges, scale operations, and achieve market leadership, leveraging their extensive network and industry expertise.
Investor Profile
Prolog Ventures has backed more than 72 startups, with 0 new investments in the last 12 months alone. The firm has led 14 rounds, about 19% of its total and boasts 15 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in United States, Canada.
- Strong thematic focus on Biotechnology, Health Care, Medical Device.
- Typical check size: $500K – $5M.
Stage Focus
- Series B (26%)
- Series Unknown (24%)
- Series A (22%)
- Series C (11%)
- Series D (7%)
- Series E (3%)
- Debt Financing (3%)
- Series F (1%)
- Series G (1%)
- Seed (1%)
Country Focus
- United States (99%)
- Canada (1%)
Industry Focus
- Biotechnology
- Health Care
- Medical Device
- Medical
- Manufacturing
- Food And Beverage
- Agriculture
- Life Science
- Therapeutics
- Service Industry
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.